Owl Creek Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-259,774
Closed -$34.7M 80
2018
Q4
$34.7M Buy
259,774
+37,675
+17% +$6.18M 1.14% 15
2018
Q3
$42.3M Buy
222,099
+41,461
+23% +$7.62M 2.03% 11
2018
Q2
$30.1M Sell
180,638
-251,265
-58% -$40.3M 0.92% 14
2018
Q1
$72.7M Buy
431,903
+41,166
+11% +$6.9M 2.95% 6
2017
Q4
$63.9M Buy
+390,737
New +$70.1M 1.56% 11
2016
Q1
Sell
-312,679
Closed -$97.7M 30
2015
Q4
$97.7M Buy
312,679
+121,438
+63% +$36.2M 5.56% 3
2015
Q3
$52M Sell
191,241
-37,320
-16% -$11.5M 2.96% 9
2015
Q2
$69.4M Sell
228,561
-210,784
-48% -$62.9M 3.72% 12
2015
Q1
$131M Buy
439,345
+62,738
+17% +$17.9M 7.06% 4
2014
Q4
$96.9M Buy
+376,607
New +$94.1M 6.14% 5

Other funds holding AGN

Owl Creek Asset Management's AGN Position: Q1 2019 in Review

Owl Creek Asset Management sold out of Allergan plc (AGN) in Q1 2019, closing a stake of 259,774 shares — an estimated $34.7M sold.

Owl Creek Asset Management first reported a position in AGN in Q4 2014 and held it in 10 quarters. The position peaked at $131M in Q1 2015. 991 funds tracked by Wall St. Rank hold AGN as of Q1 2019.

  • Owl Creek Asset Management reported no remaining Allergan plc position as of Q1 2019 after selling out during the quarter.
  • Owl Creek Asset Management sold 259,774 Allergan plc shares in Q1 2019, an estimated $34.7M.
  • Owl Creek Asset Management first reported a position in Allergan plc in Q4 2014 and held it in 10 quarters.
  • Owl Creek Asset Management's Allergan plc position peaked at $131M in Q1 2015.
  • 991 funds tracked by Wall St. Rank held Allergan plc as of Q1 2019.

Based on Owl Creek Asset Management's 13F filing for Q1 2019, filed 15 May 2019.